(Q64380098)

English

Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 i

article

Statements

Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 i (English)
0 references
Daniel M Appledorn
0 references
Yasser A Aldhamen
0 references
Sarah Godbehere
0 references
Sergey S Seregin
0 references
Andrea Amalfitano
0 references
January 2011
0 references
18
0 references
1
0 references
150-60
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit